Seeking a challenging and responsible position in an innovative research environment where I
can leverage my skills and expertise to contribute effectively to the organization’s success while
continuously enhancing my knowledge and professional growth.

Professional Experience:

Patents:

• Santhi Sree Vemulapalli

“A METHOD OF CHARACTERIZING AND EVALUATING A TARGETED DRUG DELIVERY FOR MALIGNANT

TUMOURS”.     Application No. 202341013115, South Africa Patent.

• Shanta Kumari Adiki, Santhi Sree Vemulapalli, Prakash Katakam Mucoadhesive Multi Unit Mini Patches (mmmp) in enteric coated capsules. For controlled release of

Application No.201941017288A, The Patent Office Journal No. 19/2019. Dated – 10/05/2019.

Selected Research Paper and Poster Presentations:

• Santhi Sree et al., Preparation and evaluation of Mucoadhesive multi-unit minipatches, presented in International Conference, Mangalgiri, AP conference held in Nirmala college of Pharmacy,
• Best Research Scholar Award AT APP 12^th INDO MALAYSIAN CONFERENCE (IUPS-2019)

·       Preparation and Evaluation of Mucoadhesive Microspheres in RAPID – 2017

Conference held in JNTUH, 2017.

• Project Guided for B. Pharm as well as Pharm students
• Association of Pharmacy Professionals APP Life Membership APP/TS/LM-134/20.
• An overview on Recent Patents & Technologies on solid dispersion. At JNTUH SPER conference
• Probiotics for Human use. At JNTUH SPER conference
• Formulation & Evaluation of An Occular in-situ gelling system containing combination of ofloxacin and gatifloxacin. At JNTUH SPER conference
• Formulation of oral disintegrating tablets of Amisulpride using superdisintegrants. At JNTUH SPER conference
• Analysis on dextromethorphan, Chlorphenaramine and serotonin toxicity, case report & its systematic study.
• Preparation and characterization of Lipid-Polymer Hybrid nanoparticles of Anti-Alzhemer’s drugs. At JNTUH SPER conference
• Formulation & Development of Albendazole Sustained Release tablets using Various Retarding polymers. At JNTUH SPER conference
• Formulation & Evaluation of Buccal tablets of ofloxacin. At JNTUH SPER conference